Trial Profile
Specified Drug Use resulTs survEy of IpragLifLozin treAtment in ELDERly type2 Diabetes Patients (STELLA-ELDER)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2017
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms STELLA-ELDER
- Sponsors Astellas Pharma
- 14 Oct 2015 According to ClinicalTrials.gov record, Status changed from recruiting to completed.
- 26 Nov 2014 New trial record